Pay for Performance: Reporting of Quality Metrics in HCV Infection

Pay for performance (P4P) has become the cornerstone of how the Centers for Medicare and Medicaid Services (CMS) financially incentivizes high-quality care. All gastroenterologists should know that they will be required to successfully report certain quality measures or be penalized with a reimbursement cut of −2% from Medicare.

In the current review, researchers examined the CMS P4P program in the context of hepatitis C virus (HCV) infection. Highlights include the following:

• HCV-specific quality measures include testing for genotype and HCV RNA before HCV treatment, testing HCV RNA at weeks 4 and 12 during treatment, hepatitis A vaccination, shared decision-making regarding treatment options, hepatocellular carcinoma screening, medication d…